The Patent Finder

Process for the Preparation of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methylpropyl)-PHENOL

Gruenenthal GmbH

A patent family: one line of work, grouped by real continuity rather than by a technology label inferred from titles. 2 of these applications claim priority to application PCT/EP2007/006515, filed Jul 23, 2007. A shared origin can cover several different claimed inventions, which is why members here may not share a title. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Confidence:Highevery input resolvedMediumone input unresolvedLowtwo or more caveatsUSPTO recordfrom USPTO's bulk records, without the patent's file history
PatentTitleHolderStatusExpiresPatent lifetimeUsedRemainingConfidence
US 11,739,049Process for the Preparation of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methyl-PROPYL)-PHENOL
In force
 · High confidence
UsedRemaining
Grünenthal GmbHIn forceHigh confidence
US 8,877,974Process for the Preparation of (1R,2R)-3-(3-Dimethylamino-1-Ethyl-2-Methylpropyl)-PHENOL
Grace period ended Nov 4, 2026 · lapse expected
 · Low confidence
Gruenenthal GmbHGrace period ended Nov 4, 2026
lapse expected
Low confidence
US 10,323,040Process for the Preparation of 5-Fluorotryptophol
In force
 · High confidence
Adneuris Therapeutics, Inc.In forceHigh confidence
US 11,013,701Stable Formulation for Parenteral Administration of Tapentadol
In force
 · High confidence
Gruenenthal GmbHIn forceHigh confidence
US 10,829,4803-((HETERO-)ARYL)-ALKYL-8-Amino-2-OXO-1,3-Diaza-SPIRO-[4.5]-DECANE Derivatives
In force
 · Low confidence
Grünenthal GmbHIn forceLow confidence
US 9,339,816Reactor Array for Producing and Analyzing Products
Lapsed May 17, 2020 on the fee record
High confidence
Gruenenthal GmbHLapsed May 17, 2020 on the fee recordHigh confidence
US 8,399,503Spirocyclic Azaindole Derivatives
Lapsed Mar 19, 2021 on the fee record
High confidence
Gruenenthal GmbHLapsed Mar 19, 2021 on the fee recordHigh confidence
US 8,722,086Dosage Form with Impeded Abuse
Lapsed May 13, 2022 on the fee record
High confidence
Gruenenthal GmbHLapsed May 13, 2022 on the fee recordHigh confidence
US 10,201,502Tamper-resistant tablet providing immediate drug release
Lapsed Feb 12, 2023 on the fee record
High confidence
Gruenenthal GmbHLapsed Feb 12, 2023 on the fee recordHigh confidence
US 8,008,304Substituted Propiolic Acid Amides and Their Use for Producing Drugs
Lapsed Aug 30, 2023 on the fee record
Medium confidence
Gruenenthal GmbHLapsed Aug 30, 2023 on the fee recordMedium confidence
34 more records in this group · Pro
10 of 44 records shown. In-force patents first, soonest term end first, then patent number. Expired patents follow, in the same order.
Pro members see all 44, including 10 expired and 1 expiring within the 18 months from Nov 22, 2026.
Upgrade to Pro
4 of these are in force and held by Gruenenthal GmbH.
Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) · how we know
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
The Patent Finder CompaniesExpirationsCalculatorWatchlistPricing MethodologyCorrectionsLegalPrivacysupport@thepatentfinder.com Updated Nov 22, 2026 · includes USPTO assignment data published Nov 21, 2026, status data published Nov 22, 2026 and grant & fee data published Nov 17, 2026 (weekly) Part of 137 Finder · © 2026 137 Finder LLC · Sources cited